madman
Super Moderator
Bringing you the latest and greatest!
Nelson's house is where it's at!
15:47-17:57 (T levels on therapy/sides)
* The right answer is you've got to keep testosterone within the normal range which is 200/300-1000 ng/dL but its very hard to do and make the patient feel well, they will feel better in the higher-end of that regimen rather than the lower-end
In this episode, Dr. Amy Pearlman interviews Dr. Larry lipshultz, one of the most prolific and well known hormone specialists in the world. He is Professor of Urology and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine. They explore the evolving and sometimes controversial landscape of testosterone therapy in men with a history of prostate cancer. They also discuss when testosterone may be safely considered in men who have been diagnosed with prostate cancer prior to prostate cancer treatment- emphasizing the importance of individualized care, discussions with all treating physicians, and close monitoring.
Drs. Pearlman and Lipshultz also dive into two hot topics in men’s hormone health:
* Growth Hormone Secretagogues – With growing interest but limited clinical data, I speak with Dr. Lipshultz about his experience using these medications alongside TRT.
* Fertility Preservation on TRT – What role do FSH and hCG play for men hoping to maintain or restore fertility while on testosterone? We review Dr. Lipshultz's recent research and how these therapies are being used in clinical practice.
As always, patient-centered care, shared decision-making, and a nuanced understanding of the data are key.
Nelson's house is where it's at!
15:47-17:57 (T levels on therapy/sides)
* The right answer is you've got to keep testosterone within the normal range which is 200/300-1000 ng/dL but its very hard to do and make the patient feel well, they will feel better in the higher-end of that regimen rather than the lower-end
In this episode, Dr. Amy Pearlman interviews Dr. Larry lipshultz, one of the most prolific and well known hormone specialists in the world. He is Professor of Urology and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine. They explore the evolving and sometimes controversial landscape of testosterone therapy in men with a history of prostate cancer. They also discuss when testosterone may be safely considered in men who have been diagnosed with prostate cancer prior to prostate cancer treatment- emphasizing the importance of individualized care, discussions with all treating physicians, and close monitoring.
Drs. Pearlman and Lipshultz also dive into two hot topics in men’s hormone health:
* Growth Hormone Secretagogues – With growing interest but limited clinical data, I speak with Dr. Lipshultz about his experience using these medications alongside TRT.
* Fertility Preservation on TRT – What role do FSH and hCG play for men hoping to maintain or restore fertility while on testosterone? We review Dr. Lipshultz's recent research and how these therapies are being used in clinical practice.
As always, patient-centered care, shared decision-making, and a nuanced understanding of the data are key.
